A Multi-center, Prospective, Registry Study to Analyze the Clinical Characteristics and Prognosis of Different Molecular Subtypes of Peripheral T-cell Lymphoma.
NCT07657572 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2026-06-18
Summary
A multi-center, prospective, registry study to analyze the clinical characteristics and prognosis of different molecular subtypes of peripheral T-cell lymphoma.
Conditions
- PTCL
- T Cell Lymphoma
Sponsors & Collaborators
-
Ruijin Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-06-30
- Primary Completion
- 2029-12-31
- Completion
- 2030-12-31
More Related Trials
-
Molecular and Cellular Characterization of MALT Lymphoma
NCT07376330 ·Status: NOT_YET_RECRUITING
-
Dynamic Monitoring of Plasma ctDNA for Prognostic Assessment in Patients With B-Cell Non-Hodgkin Lymphoma
NCT07480837 ·Status: ACTIVE_NOT_RECRUITING
-
Early Assessment of Lymphoma Treatment Response Using Phased Variant Analysis With Next-Generation Sequencing
NCT06550427 ·Status: RECRUITING
-
Notch 1 Mutation in Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma Patient
NCT07157579 ·Status: NOT_YET_RECRUITING
-
ctDNA Analysis to Monitor the Risk of Progression After First-line Immunotherapy in Patients With Advanced NSCLC
NCT05198154 ·Status: ACTIVE_NOT_RECRUITING
-
Study of Lymphoma in Asia
NCT01584141 ·Status: COMPLETED
-
Tumor Associated Macrophage in Advanced Non-small Cell Lung Cancer
NCT01551251 ·Status: COMPLETED
-
Evaluating the Predictive Capability of Transcriptomic Profiling for Identifying the Primary Site of Metastatic Tumors
NCT07319949 ·Status: NOT_YET_RECRUITING
-
Transcriptional Framework for the Molecular Diagnosis of Response to Immunotherapy in Lung Cancer With Agnostic Potential
NCT06807307 ·Status: RECRUITING
-
Effectiveness of Circulating DNA for Predicting the Relapse and Overall Survival in NHL Patients
NCT03079947 ·Status: UNKNOWN
-
Lymphocytes Subpopulation in Cancer Patients
NCT02516371 ·Status: UNKNOWN ·Phase: NA
-
The Value of Diagnosis and Outcome Prediction in CTC for Metastatic NPC Patients
NCT02505139 ·Status: COMPLETED
-
Immune Signature Analysis of Disease Progression in Post Immunotherapy Lung Cancer Patients
NCT05415358 ·Status: ACTIVE_NOT_RECRUITING
-
Comparative Study of microRNA Changes in Patients With Reactive Lymphoid Hyperplasia and Malignant Lymphoma
NCT03167476 ·Status: UNKNOWN
-
Tumor-specific T Cells in Lung Cancer
NCT02515760 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Multi-center Prospective Observational Biomarker Study on EGFRm+ Non-small Cell Lung Cancer Patients With Leptomeningeal Metastasis
NCT02803619 ·Status: UNKNOWN
-
The Predictive Value of Proteome Profiling for Brain Metastasis in Limited-Stage Small-Cell Lung Cancer
NCT06483919 ·Status: ACTIVE_NOT_RECRUITING
-
A Study of Chinese Adults With Lymphoma
NCT05288491 ·Status: COMPLETED
-
Evaluation of Diagnostic Value of Molecular Markers in Renal Cancer
NCT00491621 ·Status: TERMINATED ·Phase: NA
-
Multiomics Study of Biological Behavior of Lymph Node Metastasis in Papillary Thyroid Carcinoma
NCT06725628 ·Status: NOT_YET_RECRUITING
-
A Real-time and Computerized Sonographic Reporting System in Predicting Malignant Cervical Lymphadenopathy
NCT01130402 ·Status: COMPLETED
-
The Value of Monitoring Circulating Cell DNA (ctDNA) in Pediatric Lymphoma: A Prospective, Multicenter Clinical Study
NCT04957901 ·Status: RECRUITING
-
Molecular Analysis of Thoracic Malignancies
NCT01385722 ·Status: ENROLLING_BY_INVITATION
-
Biomarkers in Tumor Tissue Samples From Patients With Peripheral T-cell Lymphoma or Natural Killer Cell Neoplasms
NCT01390597 ·Status: COMPLETED
-
Immune Checkpoint Inhibitors in Advanced Non-small Cell Lung Cancer and Discovery of New Biomarkers
NCT03658460 ·Status: COMPLETED